Feasibility and potency of a IL-12-secreting multi-antigen dendritic cell vaccine in patients with leukemia and myeloma: a two-center trial
Pilot study of neo-adjuvant treatment with galectin-3 inhibitor, GM-CT-01, to stimulate anergized anti-cancer T lymphocytes in ovarian cancer
